<DOC>
	<DOCNO>NCT00452868</DOCNO>
	<brief_summary>RATIONALE : Donepezil may decrease side effect cause radiation therapy brain . PURPOSE : This clinical trial study well donepezil work treat young patient primary brain tumor previously treat radiation therapy brain .</brief_summary>
	<brief_title>Donepezil Treating Young Patients With Primary Brain Tumors Previously Treated With Radiation Therapy Brain</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine impact donepezil hydrochloride cognitive function pediatric patient primary brain tumor previously treat cranial radiotherapy . Secondary - Assess health-related quality life patient treated drug . - Assess function quality life family patient treated drug . - Determine physiologic effect radiotherapy cerebrovascular hemodynamics patient treated drug . - Determine toxicity donepezil hydrochloride patient . OUTLINE : This multicenter , pilot , open-label , control study . Patients receive oral donepezil hydrochloride daily every day 24 week absence disease progression unacceptable toxicity . After completion 6 week study therapy , patient evaluate toxicity . Patients experience adverse effect treatment may continue receive donepezil hydrochloride high dose 18 week . Patients undergo measurement cognitive function ( neurocognitive testing ) , behavioral adjustment social competency ( parent-reported questionnaire ) , health-related quality life ( child- parent-reported questionnaire ) , vascular dynamic ( transcranial Doppler ultrasound ) baseline week 12 , 24 , 36 . Family function family quality life assess baseline week 24 . PROJECTED ACCRUAL : A total 35 patient accrue study .</detailed_description>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Neurotoxicity Syndromes</mesh_term>
	<mesh_term>Radiation Injuries</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>Prior diagnosis primary brain tumor No type 2 neurofibromatosis Underwent fractionate radiotherapy ( ≥ 23.4 Gy ) without surgery chemotherapy brain tumor least 1 year ago Karnofsky Lansky performance status 70100 % Fertile patient willing use effective contraception Baseline IQ ≥ 70 Peabody Picture Vocabulary Test3 Stable weight within past 6 month concern weight loss Vision aid hear aid must use neuropsychologic/neurocognitive test , If indicate Able speak English More 6 week since prior donepezil hydrochloride , EGb761 , methylphenidate hydrochloride , stimulant , cognitive functionenhancing drug Stereotactic radiosurgery sole treatment Evidence disease progression MRI Pregnant nursing Attentiondeficit/hyperactivity disorder cancer diagnosis Uncontrolled seizure uncontrolled endocrinopathies Uncontrolled comorbidities Steroid dose great physiologic replacement ( 1830 mg/m² hydrocortisone equivalent ) Use concurrent anticholinergic drug</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>cognitive/functional effect</keyword>
	<keyword>neurotoxicity</keyword>
	<keyword>long-term effect secondary cancer therapy child</keyword>
	<keyword>psychosocial effect cancer treatment</keyword>
	<keyword>radiation toxicity</keyword>
	<keyword>childhood central nervous system germ cell tumor</keyword>
	<keyword>childhood choroid plexus tumor</keyword>
	<keyword>childhood craniopharyngioma</keyword>
	<keyword>childhood grade I meningioma</keyword>
	<keyword>childhood grade II meningioma</keyword>
	<keyword>childhood grade III meningioma</keyword>
	<keyword>childhood spinal cord neoplasm</keyword>
	<keyword>childhood brain stem glioma</keyword>
	<keyword>childhood cerebellar astrocytoma</keyword>
	<keyword>childhood medulloblastoma</keyword>
	<keyword>childhood supratentorial primitive neuroectodermal tumor</keyword>
	<keyword>childhood visual pathway hypothalamic glioma</keyword>
	<keyword>childhood subependymal giant cell astrocytoma</keyword>
	<keyword>childhood ependymoma</keyword>
	<keyword>childhood cerebral astrocytoma/malignant glioma</keyword>
</DOC>